|
|
||||||||
CASE STUDIES |
Department of Cardiothoracic Surgery
1 Department of Nephrology
2 Department of Pulmonology
3 Department of Cardiology, Memorial Hospital, Belleville, USA
For reprint information contact: Hon Chi Suen, MD Tel: 1 618 233 5722 Fax: 1 618 233 7069 Email: HSUEN{at}earthlink.net, Cardiothoracic Surgery Associates, S.C., 12B Park Place, Swansea, IL 62226, USA
High-dose propofol infusion for sedation of patients in the intensive care unit can result in rhabdomyolysis, acute renal failure, metabolic acidosis, hyperkalemia, ventricular arrhythmia, hyperthermia, and death. The death of a patient with such complications after lung biopsy is reported. Until a safer dosage range has been determined, propofol infusion at rates higher than 5 mg·kg1·h1 should be discouraged for long-term sedation (> 48 h).
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |